Low Concentration of 5-Fluorouracil Increases the Effectiveness of Tumor RNA to Activate Murine Dendritic Cells
Nenhuma Miniatura disponível
Camargo, Marcela Rodrigues de [UNESP]
Gorgulho, Carolina Mendonca [UNESP]
Rodrigues, Cecilia Pessoa [UNESP]
Longo Frederico, Juliana Cristina [UNESP]
Marchesan Rodrigues, Maria Aparecida [UNESP]
Kaneno, Ramon [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Mary Ann Liebert, Inc
Aim: Considering the central role of dendritic cells (DCs) on the development of an antitumor immune response, in this study we used a murine model to evaluate how DC transfection with drug-treated tumor cell RNA changes their phenotype, and whether transfection enhances the in vivo effectiveness of a DC-based antitumor vaccine. Materials and Methods: MC-38 colorectal tumor cells were pretreated with the minimum effective concentration of 5-fluorouracil (5-FU), then their total RNA was extracted and transfected into DCs. These DCs were inoculated into C57Bl/6 mice bearing subcutaneous MC-38 tumor. Results: DC transfection with drug-treated tumor RNA increases the percentages of CD40(+) (from 37.6% to 61.4%), CD86(+) (from 39.8% to 53.4%), and major histocompatibility complex class II+ (from 51.2% to 75.3%) cells, whereas significantly increases the in vivo generation of interferon-c producer lymphocytes. Conclusion: These results reinforce our view that treatment of tumor cells with 5-FU induces transcriptional changes that can be transferred to DCs by RNA transfection, enhancing their ability to stimulate an antitumor response.
chemotherapy, colorectal cancer, dendritic cell, immunomodulation, vaccine
Cancer Biotherapy And Radiopharmaceuticals. New Rochelle: Mary Ann Liebert, Inc, v. 32, n. 8, p. 302-308, 2017.